Related references
Note: Only part of the references are listed.Polypeptide nanoformulation-induced immunogenic cell death and remission of immunosuppression for enhanced chemoimmunotherapy
Xiangru Feng et al.
SCIENCE BULLETIN (2021)
Targeted pH-responsive polyion complex micelle for controlled intracellular drug delivery
Pan Zheng et al.
CHINESE CHEMICAL LETTERS (2020)
Dual-acidity-labile polysaccharide-di-drugs conjugate for targeted cancer chemotherapy
Di Li et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Temozolomide, Gemcitabine, and Decitabine Hybrid Nanoconjugates: From Design to Proof-of-Concept (PoC) of Synergies toward the Understanding of Drug Impact on Human Glioblastoma Cells
Ferdaous Sahli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Spatiotemporally Targeted Nanomedicine Overcomes Hypoxia-Induced Drug Resistance of Tumor Cells after Disrupting Neovasculature
Jinjin Chen et al.
NANO LETTERS (2020)
Synergistically Enhanced Antimetastasis Effects by Honokiol-Loaded pH-Sensitive Polymer-Doxorubicin Conjugate Micelles
Yang Zou et al.
ACS APPLIED MATERIALS & INTERFACES (2018)
Enhanced efficacy of combined temozolomide and bromodomain inhibitor therapy for gliomas using targeted nanoparticles
Fred C. Lam et al.
NATURE COMMUNICATIONS (2018)
Polymer - Temozolomide Conjugates as Therapeutics for Treating Glioblastoma
Sarah M. Ward et al.
MOLECULAR PHARMACEUTICS (2018)
Targeted Theranostic Nanoparticles for Brain Tumor Treatment
Maria Mendes et al.
PHARMACEUTICS (2018)
Enhancement of temozolomide stability by loading in chitosan-carboxylated polylactide-based nanoparticles
Antonio Di Martino et al.
JOURNAL OF NANOPARTICLE RESEARCH (2017)
Versatile Synthesis of Polymer-Temozolomide Conjugates
Matthew Skinner et al.
ACS MACRO LETTERS (2017)
Thermoresponsive nanocomposite gel for local drug delivery to suppress the growth of glioma by inducing autophagy
Li Ding et al.
AUTOPHAGY (2017)
Nanocarriers for cancer-targeted drug delivery
Preeti Kumari et al.
JOURNAL OF DRUG TARGETING (2016)
Nanocarriers for the treatment of glioblastoma multiforme: Current state-of-the-art
Reatul Karim et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Temozolomide Nanoparticles for Targeted Glioblastoma Therapy
Chen Fang et al.
ACS APPLIED MATERIALS & INTERFACES (2015)
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2015)
Combined Delivery of Temozolomide and Anti-miR221 PNA Using Mesoporous Silica Nanoparticles Induces Apoptosis in Resistant Glioma Cells
Alessandro Bertucci et al.
SMALL (2015)
Polymer therapeutics-prospects for 21st century: The end of the beginning
Ruth Duncan et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
Glioblastoma and Other Malignant Gliomas A Clinical Review
Antonio Omuro et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Nanoparticle-based combination therapy toward overcoming drug resistance in cancer
Che-Ming Jack Hu et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Enhanced stability and activity of temozolomide in primary glioblastoma multiforme cells with cucurbit[n]uril
Eric A. Appel et al.
CHEMICAL COMMUNICATIONS (2012)
Polymeric Conjugates for Drug Delivery
Nate Larson et al.
CHEMISTRY OF MATERIALS (2012)
Crystal Engineering of Stable Temozolomide Cocrystals
N. Jagadeesh Babu et al.
CHEMISTRY-AN ASIAN JOURNAL (2012)
Repeated injections of PEGylated liposomal topotecan induces accelerated blood clearance phenomenon in rats
Yanling Ma et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
A frustrating problem: Accelerated blood clearance of PEGylated solid lipid nanoparticles following subcutaneous injection in rats
Yongxue Zhao et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2012)
Temozolomide loaded PLGA-based superparamagnetic nanoparticles for magnetic resonance imaging and treatment of malignant glioma
You Ling et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2012)
Partial Hydrolysis of Poly(2-ethyl-2-oxazoline) and Potential Implications for Biomedical Applications?
Huub P. C. Van Kuringen et al.
MACROMOLECULAR BIOSCIENCE (2012)
Poly(2-ethyl-2-oxazoline) as Alternative for the Stealth Polymer Poly(ethylene glycol): Comparison of in vitro Cytotoxicity and Hemocompatibility
Marius Bauer et al.
MACROMOLECULAR BIOSCIENCE (2012)
Poly(2-oxazoline)s and Related Pseudo-Polypeptides
Helmut Schlaad et al.
MACROMOLECULAR RAPID COMMUNICATIONS (2012)
Poly(2-oxazoline)s as Polymer Therapeutics
Robert Luxenhofer et al.
MACROMOLECULAR RAPID COMMUNICATIONS (2012)
Poly(2-Oxazoline)s - Are They More Advantageous for Biomedical Applications Than Other Polymers?
Ondrej Sedlacek et al.
MACROMOLECULAR RAPID COMMUNICATIONS (2012)
Nanodelivery strategies in cancer chemotherapy: biological rationale and pharmaceutical perspectives
George Mattheolabakis et al.
NANOMEDICINE (2012)
Synthesis, characterization and biocompatibility of poly(2-ethyl-2-oxazoline)-poly(D,L-lactide)-poly(2-ethyl-2-oxazoline) hydrogels
X. Wang et al.
ACTA BIOMATERIALIA (2011)
Structure-property relationship in cytotoxicity and cell uptake of poly(2-oxazoline) amphiphiles
Robert Luxenhofer et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Overcoming the PEG-addiction: well-defined alternatives to PEG, from structure-property relationships to better defined therapeutics
Matthias Barz et al.
POLYMER CHEMISTRY (2011)
Temozolomide: Mechanisms of Action, Repair and Resistance
Jihong Zhang et al.
Current Molecular Pharmacology (2011)
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
Katrin Knop et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2010)
Efficient delivery of liposome-mediated MGMT-siRNA reinforces the cytotoxity of temozolomide in GBM-initiating cells
T. Kato et al.
GENE THERAPY (2010)
CpG motifs in pDNA-sequences increase anti-PEG IgM production induced by PEG-coated pDNA-lipoplexes
Tatsuaki Tagami et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Temozolomide Delivery to Tumor Cells by a Multifunctional Nano Vehicle Based on Poly(β-L-malic acid)
Rameshwar Patil et al.
PHARMACEUTICAL RESEARCH (2010)
Poly(2-oxazoline)s: A Polymer Class with Numerous Potential Applications
Richard Hoogenboom
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)
New strategies to deliver anticancer drugs to brain tumors
Valentino Laquintana et al.
EXPERT OPINION ON DRUG DELIVERY (2009)
Glioblastoma multiforme: a review of where we have been and where we are going
Cory Adamson et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Polymer-drug conjugates: Recent development in clinical oncology
Chun Li et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
Malignant gliomas in adults
Patrick Y. Wen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The 2007 WHO classification of tumours of the central nervous system (vol 114, pg 97, 2007)
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2007)
Polymer-drug conjugation, recent achievements and general strategies
G. Pasut et al.
PROGRESS IN POLYMER SCIENCE (2007)
Antibody against poly(ethylene glycol) adversely affects PEG-asparaginase therapy in acute lymphoblastic leukemia patients
Jonathan K. Armstrong et al.
CANCER (2007)
PEG-doxorubicin conjugates: Influence of polymer structure on drug release, in vitro cytotoxicity, biodistribution, and antitumor activity
FM Veronese et al.
BIOCONJUGATE CHEMISTRY (2005)
The blood-brain barrier: an overview - Structure, regulation, and clinical implications
P Ballabh et al.
NEUROBIOLOGY OF DISEASE (2004)
Amphiphilic diblock copolymers based on poly(2-ethyl-2-oxazoline) and poly(1,3-trimethylene carbonate): Synthesis and micellar characteristics
C Kim et al.
MACROMOLECULES (2000)
Antitumour imidazotetrazines. Part 39. Synthesis of bis(imidazotetrazine)s with saturated spacer groups
J Arrowsmith et al.
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1 (2000)
Synthesis of starlike N-(2-hydroxypropyl)methacrylamide copolymers: Potential drug carriers
D Wang et al.
BIOMACROMOLECULES (2000)
Share Paper
